nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Exacerbation of asthma—Mesalazine—Crohn's disease	0.0169	0.0635	CcSEcCtD
Bimatoprost—Dinoprostone—PTGER4—Crohn's disease	0.0156	0.721	CrCbGaD
Bimatoprost—Uveitis—Azathioprine—Crohn's disease	0.0138	0.0521	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Mercaptopurine—Crohn's disease	0.0136	0.0513	CcSEcCtD
Bimatoprost—Eye swelling—Mesalazine—Crohn's disease	0.0135	0.0509	CcSEcCtD
Bimatoprost—Urine abnormality—Mesalazine—Crohn's disease	0.00795	0.0299	CcSEcCtD
Bimatoprost—Hirsutism—Mesalazine—Crohn's disease	0.00758	0.0285	CcSEcCtD
Bimatoprost—Urine analysis abnormal—Mesalazine—Crohn's disease	0.00749	0.0282	CcSEcCtD
Bimatoprost—Burning sensation—Mesalazine—Crohn's disease	0.00634	0.0239	CcSEcCtD
Bimatoprost—Hypertrichosis—Prednisone—Crohn's disease	0.00613	0.0231	CcSEcCtD
Bimatoprost—Tafluprost—PTGS2—Crohn's disease	0.00602	0.279	CrCbGaD
Bimatoprost—Scotoma—Mesalazine—Crohn's disease	0.0058	0.0218	CcSEcCtD
Bimatoprost—Skin discolouration—Mesalazine—Crohn's disease	0.00488	0.0183	CcSEcCtD
Bimatoprost—Cough increased—Mesalazine—Crohn's disease	0.00481	0.0181	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00461	0.00651	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00459	0.00649	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—GPR65—Crohn's disease	0.00459	0.00647	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—GPR65—Crohn's disease	0.00449	0.00634	CbGpPWpGaD
Bimatoprost—AKR1C3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00438	0.00618	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00437	0.00617	CbGpPWpGaD
Bimatoprost—Cystitis noninfective—Mesalazine—Crohn's disease	0.0043	0.0162	CcSEcCtD
Bimatoprost—Cystitis—Mesalazine—Crohn's disease	0.00425	0.016	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.0041	0.00579	CbGpPWpGaD
Bimatoprost—Dry eye—Mesalazine—Crohn's disease	0.00407	0.0153	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00406	0.00573	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—GPX4—Crohn's disease	0.00402	0.00568	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00401	0.00567	CbGpPWpGaD
Bimatoprost—Hirsutism—Prednisone—Crohn's disease	0.00401	0.0151	CcSEcCtD
Bimatoprost—Bladder pain—Mesalazine—Crohn's disease	0.00398	0.015	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00381	0.00538	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ACKR2—Crohn's disease	0.00379	0.00535	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00373	0.00527	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ACKR2—Crohn's disease	0.00371	0.00523	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCR6—Crohn's disease	0.00364	0.00514	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—MLN—Crohn's disease	0.00359	0.00507	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00354	0.005	CbGpPWpGaD
Bimatoprost—Eye pain—Mesalazine—Crohn's disease	0.00354	0.0133	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—MLN—Crohn's disease	0.00351	0.00496	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00347	0.0049	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00338	0.00477	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCR9—Crohn's disease	0.00333	0.0047	CbGpPWpGaD
Bimatoprost—Arthritis—Mesalazine—Crohn's disease	0.00329	0.0124	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00327	0.00461	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0032	0.00451	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—GPR65—Crohn's disease	0.00309	0.00437	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00304	0.00429	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.003	0.0113	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00297	0.0042	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00297	0.0042	CbGpPWpGaD
Bimatoprost—Liver function test abnormal—Mesalazine—Crohn's disease	0.00295	0.0111	CcSEcCtD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00295	0.00416	CbGpPWpGaD
Bimatoprost—Dry skin—Mesalazine—Crohn's disease	0.00293	0.011	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00289	0.00409	CbGpPWpGaD
Bimatoprost—Nasopharyngitis—Mesalazine—Crohn's disease	0.00286	0.0108	CcSEcCtD
Bimatoprost—Skin disorder—Mercaptopurine—Crohn's disease	0.00281	0.0106	CcSEcCtD
Bimatoprost—Asthma—Mesalazine—Crohn's disease	0.00276	0.0104	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—MLN—Crohn's disease	0.00271	0.00383	CbGpPWpGaD
Bimatoprost—Bronchitis—Mesalazine—Crohn's disease	0.00266	0.01	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—ACKR2—Crohn's disease	0.0026	0.00367	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00257	0.00966	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00255	0.0036	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00253	0.00357	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00252	0.00356	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.0025	0.00941	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCR9—Crohn's disease	0.00249	0.00351	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00247	0.00349	CbGpPWpGaD
Bimatoprost—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00246	0.00927	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—MLN—Crohn's disease	0.00246	0.00348	CbGpPWpGaD
Bimatoprost—Depression—Mesalazine—Crohn's disease	0.00246	0.00924	CcSEcCtD
Bimatoprost—Cataract—Prednisone—Crohn's disease	0.00245	0.00921	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR9—Crohn's disease	0.00243	0.00344	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00237	0.00335	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00232	0.00328	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—GPR65—Crohn's disease	0.00231	0.00327	CbGpPWpGaD
Bimatoprost—Sinusitis—Mesalazine—Crohn's disease	0.00231	0.0087	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—GPR65—Crohn's disease	0.00226	0.0032	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00222	0.00314	CbGpPWpGaD
Bimatoprost—Rhinitis—Mesalazine—Crohn's disease	0.00222	0.00834	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CCR6—Crohn's disease	0.0022	0.00311	CbGpPWpGaD
Bimatoprost—Pharyngitis—Mesalazine—Crohn's disease	0.00219	0.00826	CcSEcCtD
Bimatoprost—Mediastinal disorder—Azathioprine—Crohn's disease	0.00219	0.00823	CcSEcCtD
Bimatoprost—Oedema peripheral—Mesalazine—Crohn's disease	0.00218	0.0082	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00218	0.00307	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Mesalazine—Crohn's disease	0.00217	0.00818	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00216	0.00306	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00215	0.00303	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00212	0.00299	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00212	0.00299	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00207	0.00293	CbGpPWpGaD
Bimatoprost—Eye disorder—Mesalazine—Crohn's disease	0.00207	0.00778	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—MLN—Crohn's disease	0.00203	0.00286	CbGpPWpGaD
Bimatoprost—Angiopathy—Mesalazine—Crohn's disease	0.00201	0.00755	CcSEcCtD
Bimatoprost—Mediastinal disorder—Mesalazine—Crohn's disease	0.00199	0.0075	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—MLN—Crohn's disease	0.00199	0.0028	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ACKR2—Crohn's disease	0.00194	0.00274	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—PTGER4—Crohn's disease	0.00194	0.00274	CbGpPWpGaD
Bimatoprost—Erythema—Mesalazine—Crohn's disease	0.00193	0.00725	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.0019	0.00269	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ACKR2—Crohn's disease	0.0019	0.00268	CbGpPWpGaD
Bimatoprost—Tension—Mesalazine—Crohn's disease	0.00189	0.00711	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR9—Crohn's disease	0.00188	0.00265	CbGpPWpGaD
Bimatoprost—Nervousness—Mesalazine—Crohn's disease	0.00187	0.00704	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00186	0.00263	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MLN—Crohn's disease	0.00184	0.0026	CbGpPWpGaD
Bimatoprost—Rash—Mercaptopurine—Crohn's disease	0.00183	0.00687	CcSEcCtD
Bimatoprost—Dermatitis—Mercaptopurine—Crohn's disease	0.00182	0.00686	CcSEcCtD
Bimatoprost—Vision blurred—Mesalazine—Crohn's disease	0.00181	0.00683	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—MLN—Crohn's disease	0.0018	0.00255	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00179	0.00672	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—GPR65—Crohn's disease	0.00175	0.00247	CbGpPWpGaD
Bimatoprost—Vertigo—Mesalazine—Crohn's disease	0.00173	0.00651	CcSEcCtD
Bimatoprost—Nausea—Mercaptopurine—Crohn's disease	0.00172	0.00647	CcSEcCtD
Bimatoprost—Infection—Azathioprine—Crohn's disease	0.00171	0.00645	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCR9—Crohn's disease	0.00171	0.00241	CbGpPWpGaD
Bimatoprost—Palpitations—Mesalazine—Crohn's disease	0.0017	0.0064	CcSEcCtD
Bimatoprost—Cough—Mesalazine—Crohn's disease	0.00168	0.00632	CcSEcCtD
Bimatoprost—Skin disorder—Azathioprine—Crohn's disease	0.00168	0.00631	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00167	0.00236	CbGpPWpGaD
Bimatoprost—Hypertension—Mesalazine—Crohn's disease	0.00166	0.00626	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCR6—Crohn's disease	0.00165	0.00233	CbGpPWpGaD
Bimatoprost—Chest pain—Mesalazine—Crohn's disease	0.00164	0.00617	CcSEcCtD
Bimatoprost—Anxiety—Mesalazine—Crohn's disease	0.00163	0.00615	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00163	0.00613	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR6—Crohn's disease	0.00161	0.00228	CbGpPWpGaD
Bimatoprost—Dry mouth—Mesalazine—Crohn's disease	0.0016	0.00603	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—GPR65—Crohn's disease	0.00159	0.00224	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00157	0.00221	CbGpPWpGaD
Bimatoprost—Infection—Mesalazine—Crohn's disease	0.00156	0.00587	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—Crohn's disease	0.00155	0.00583	CcSEcCtD
Bimatoprost—Nervous system disorder—Mesalazine—Crohn's disease	0.00154	0.0058	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—ACKR2—Crohn's disease	0.00153	0.00217	CbGpPWpGaD
Bimatoprost—Skin disorder—Mesalazine—Crohn's disease	0.00153	0.00574	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00149	0.0056	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—MLN—Crohn's disease	0.00145	0.00205	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—PTGER4—Crohn's disease	0.00145	0.00205	CbGpPWpGaD
Bimatoprost—Insomnia—Mesalazine—Crohn's disease	0.00142	0.00535	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—PTGER4—Crohn's disease	0.00142	0.002	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR9—Crohn's disease	0.00141	0.00198	CbGpPWpGaD
Bimatoprost—Dyspnoea—Mesalazine—Crohn's disease	0.0014	0.00527	CcSEcCtD
Bimatoprost—Somnolence—Mesalazine—Crohn's disease	0.0014	0.00526	CcSEcCtD
Bimatoprost—Dyspepsia—Mesalazine—Crohn's disease	0.00138	0.0052	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR9—Crohn's disease	0.00138	0.00194	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00136	0.0051	CcSEcCtD
Bimatoprost—Pain—Mesalazine—Crohn's disease	0.00134	0.00506	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—TAGAP—Crohn's disease	0.00133	0.00188	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—GPR65—Crohn's disease	0.00131	0.00185	CbGpPWpGaD
Bimatoprost—Depression—Prednisone—Crohn's disease	0.0013	0.00489	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—GPR65—Crohn's disease	0.00128	0.00181	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR9—Crohn's disease	0.00128	0.0018	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR9—Crohn's disease	0.00125	0.00176	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR6—Crohn's disease	0.00125	0.00176	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—GPR65—Crohn's disease	0.00119	0.00168	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RSPO3—Crohn's disease	0.00117	0.00166	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00117	0.00166	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RSPO3—Crohn's disease	0.00116	0.00164	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—GPR65—Crohn's disease	0.00116	0.00164	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Prednisone—Crohn's disease	0.00115	0.00433	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—ACKR2—Crohn's disease	0.00115	0.00162	CbGpPWpGaD
Bimatoprost—Dizziness—Azathioprine—Crohn's disease	0.00114	0.00429	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCR6—Crohn's disease	0.00113	0.0016	CbGpPWpGaD
Bimatoprost—Asthenia—Mesalazine—Crohn's disease	0.00113	0.00424	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—PLA2G4F—Crohn's disease	0.00112	0.00159	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ACKR2—Crohn's disease	0.00112	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SEL1L—Crohn's disease	0.00111	0.00157	CbGpPWpGaD
Bimatoprost—Pruritus—Mesalazine—Crohn's disease	0.00111	0.00418	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—SEL1L—Crohn's disease	0.0011	0.00156	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PTGER4—Crohn's disease	0.0011	0.00155	CbGpPWpGaD
Bimatoprost—Eye disorder—Prednisone—Crohn's disease	0.00109	0.00412	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—MLN—Crohn's disease	0.00109	0.00154	CbGpPWpGaD
Bimatoprost—Rash—Azathioprine—Crohn's disease	0.00109	0.00409	CcSEcCtD
Bimatoprost—Dermatitis—Azathioprine—Crohn's disease	0.00109	0.00409	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—ACKR2—Crohn's disease	0.00108	0.00153	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00108	0.00153	CbGpPWpGaD
Bimatoprost—Headache—Azathioprine—Crohn's disease	0.00108	0.00407	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—MLN—Crohn's disease	0.00106	0.0015	CbGpPWpGaD
Bimatoprost—Angiopathy—Prednisone—Crohn's disease	0.00106	0.004	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00106	0.00149	CbGpPWpGaD
Bimatoprost—Dizziness—Mesalazine—Crohn's disease	0.00104	0.00391	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00103	0.00146	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MLN—Crohn's disease	0.00103	0.00145	CbGpPWpGaD
Bimatoprost—Nausea—Azathioprine—Crohn's disease	0.00102	0.00386	CcSEcCtD
Bimatoprost—Erythema—Prednisone—Crohn's disease	0.00102	0.00383	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00101	0.00143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR9—Crohn's disease	0.00101	0.00142	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—LTF—Crohn's disease	0.000997	0.00141	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PTGER4—Crohn's disease	0.000996	0.00141	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TAGAP—Crohn's disease	0.000995	0.0014	CbGpPWpGaD
Bimatoprost—Rash—Mesalazine—Crohn's disease	0.000991	0.00373	CcSEcCtD
Bimatoprost—Dermatitis—Mesalazine—Crohn's disease	0.00099	0.00372	CcSEcCtD
Bimatoprost—Headache—Mesalazine—Crohn's disease	0.000984	0.0037	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—TAGAP—Crohn's disease	0.000974	0.00138	CbGpPWpGaD
Bimatoprost—Vision blurred—Prednisone—Crohn's disease	0.00096	0.00361	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—MTMR3—Crohn's disease	0.000956	0.00135	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TAGAP—Crohn's disease	0.00094	0.00133	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—GPR65—Crohn's disease	0.000938	0.00132	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL3—Crohn's disease	0.000934	0.00132	CbGpPWpGaD
Bimatoprost—Nausea—Mesalazine—Crohn's disease	0.000933	0.00351	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000932	0.00132	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR6—Crohn's disease	0.000931	0.00131	CbGpPWpGaD
Bimatoprost—Vertigo—Prednisone—Crohn's disease	0.000915	0.00344	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR6—Crohn's disease	0.000911	0.00129	CbGpPWpGaD
Bimatoprost—PTGER3—smooth muscle tissue—Crohn's disease	0.000904	0.203	CbGeAlD
Bimatoprost—PTGER3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000903	0.00128	CbGpPWpGaD
Bimatoprost—Hypertension—Prednisone—Crohn's disease	0.000879	0.00331	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—RSPO3—Crohn's disease	0.00087	0.00123	CbGpPWpGaD
Bimatoprost—Anxiety—Prednisone—Crohn's disease	0.000864	0.00325	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000861	0.00324	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—RSPO3—Crohn's disease	0.000851	0.0012	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL3—Crohn's disease	0.000848	0.0012	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR6—Crohn's disease	0.000846	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR6—Crohn's disease	0.000828	0.00117	CbGpPWpGaD
Bimatoprost—Infection—Prednisone—Crohn's disease	0.000826	0.00311	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—SEL1L—Crohn's disease	0.000824	0.00116	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RSPO3—Crohn's disease	0.000821	0.00116	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—RASGRP1—Crohn's disease	0.00082	0.00116	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PTGER4—Crohn's disease	0.00082	0.00116	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Prednisone—Crohn's disease	0.000815	0.00307	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—Crohn's disease	0.000807	0.00304	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—SEL1L—Crohn's disease	0.000807	0.00114	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GCKR—Crohn's disease	0.000804	0.00114	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000802	0.00113	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SEL1L—Crohn's disease	0.000779	0.0011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR9—Crohn's disease	0.000754	0.00106	CbGpPWpGaD
Bimatoprost—Insomnia—Prednisone—Crohn's disease	0.000752	0.00283	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PTGER4—Crohn's disease	0.000744	0.00105	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—FADS1—Crohn's disease	0.000744	0.00105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR9—Crohn's disease	0.000738	0.00104	CbGpPWpGaD
Bimatoprost—Dyspepsia—Prednisone—Crohn's disease	0.000732	0.00275	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PTGER4—Crohn's disease	0.000729	0.00103	CbGpPWpGaD
Bimatoprost—PTGFR—smooth muscle tissue—Crohn's disease	0.000722	0.162	CbGeAlD
Bimatoprost—PTGER3—digestive system—Crohn's disease	0.000713	0.16	CbGeAlD
Bimatoprost—AKR1C3—Signaling Pathways—CCR9—Crohn's disease	0.000712	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC11A1—Crohn's disease	0.000711	0.001	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL8—Crohn's disease	0.00071	0.001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GPR65—Crohn's disease	0.000701	0.00099	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL3—Crohn's disease	0.000698	0.000986	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000697	0.000985	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX4—Crohn's disease	0.000697	0.000984	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GPR65—Crohn's disease	0.000686	0.000969	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL3—Crohn's disease	0.000683	0.000965	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000683	0.000964	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000675	0.000954	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GCKR—Crohn's disease	0.000673	0.000951	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR6—Crohn's disease	0.000668	0.000943	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GPR65—Crohn's disease	0.000662	0.000935	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000661	0.000933	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000654	0.000924	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL3—Crohn's disease	0.000634	0.000895	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL3—Crohn's disease	0.000621	0.000876	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—RASGRP1—Crohn's disease	0.000613	0.000866	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RBX1—Crohn's disease	0.000609	0.00086	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HSPA1B—Crohn's disease	0.000609	0.00086	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RBX1—Crohn's disease	0.000604	0.000853	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—RASGRP1—Crohn's disease	0.0006	0.000848	CbGpPWpGaD
Bimatoprost—Asthenia—Prednisone—Crohn's disease	0.000596	0.00224	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—IL2RA—Crohn's disease	0.000594	0.000839	CbGpPWpGaD
Bimatoprost—Pruritus—Prednisone—Crohn's disease	0.000588	0.00221	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PTGER4—Crohn's disease	0.000588	0.00083	CbGpPWpGaD
Bimatoprost—AKR1C3—smooth muscle tissue—Crohn's disease	0.000587	0.132	CbGeAlD
Bimatoprost—Dizziness—Prednisone—Crohn's disease	0.00055	0.00207	CcSEcCtD
Bimatoprost—AKR1C3—Disease—UBE2D1—Crohn's disease	0.000534	0.000754	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL8—Crohn's disease	0.000531	0.00075	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—UBE2D1—Crohn's disease	0.00053	0.000748	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000529	0.000747	CbGpPWpGaD
Bimatoprost—AKR1C3—mammalian vulva—Crohn's disease	0.000528	0.119	CbGeAlD
Bimatoprost—Rash—Prednisone—Crohn's disease	0.000524	0.00197	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—Crohn's disease	0.000524	0.00197	CcSEcCtD
Bimatoprost—Headache—Prednisone—Crohn's disease	0.000521	0.00196	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL8—Crohn's disease	0.00052	0.000734	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000518	0.000731	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RIPK2—Crohn's disease	0.000514	0.000725	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL3—Crohn's disease	0.000501	0.000707	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR6—Crohn's disease	0.0005	0.000705	CbGpPWpGaD
Bimatoprost—Nausea—Prednisone—Crohn's disease	0.000494	0.00186	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2RA—Crohn's disease	0.000489	0.000691	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR6—Crohn's disease	0.000489	0.00069	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RASGRP1—Crohn's disease	0.000485	0.000684	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000481	0.000679	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000479	0.000676	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR6—Crohn's disease	0.000472	0.000666	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RBX1—Crohn's disease	0.000452	0.000638	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2RA—Crohn's disease	0.000444	0.000627	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RBX1—Crohn's disease	0.000442	0.000624	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTGER4—Crohn's disease	0.00044	0.000621	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—JAK2—Crohn's disease	0.00044	0.000621	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SOCS1—Crohn's disease	0.000439	0.00062	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2RA—Crohn's disease	0.000435	0.000614	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTGER4—Crohn's disease	0.00043	0.000608	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RBX1—Crohn's disease	0.000427	0.000602	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000421	0.000594	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—TYK2—Crohn's disease	0.000419	0.000591	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTGER4—Crohn's disease	0.000415	0.000586	CbGpPWpGaD
Bimatoprost—PTGER3—lymph node—Crohn's disease	0.000408	0.0915	CbGeAlD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000401	0.000567	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—JAK2—Crohn's disease	0.000399	0.000564	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—UBE2D1—Crohn's disease	0.000396	0.000559	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—UBE2D1—Crohn's disease	0.000388	0.000547	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RIPK2—Crohn's disease	0.000384	0.000542	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SMAD3—Crohn's disease	0.000382	0.00054	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SMAD3—Crohn's disease	0.000379	0.000535	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RIPK2—Crohn's disease	0.000376	0.000531	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL3—Crohn's disease	0.000375	0.000529	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—UBE2D1—Crohn's disease	0.000374	0.000528	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL3—Crohn's disease	0.000367	0.000518	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—Crohn's disease	0.000364	0.000515	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RIPK2—Crohn's disease	0.000363	0.000512	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RASGRP1—Crohn's disease	0.000362	0.000512	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RASGRP1—Crohn's disease	0.000355	0.000501	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL3—Crohn's disease	0.000354	0.000499	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2RA—Crohn's disease	0.000351	0.000495	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RASGRP1—Crohn's disease	0.000342	0.000483	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—JAK2—Crohn's disease	0.000329	0.000464	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SOCS1—Crohn's disease	0.000328	0.000463	CbGpPWpGaD
Bimatoprost—PTGFR—lymph node—Crohn's disease	0.000326	0.0731	CbGeAlD
Bimatoprost—PTGER1—GPCR downstream signaling—JAK2—Crohn's disease	0.000322	0.000454	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SOCS1—Crohn's disease	0.000321	0.000454	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TYK2—Crohn's disease	0.000313	0.000442	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SOCS1—Crohn's disease	0.00031	0.000438	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TYK2—Crohn's disease	0.000306	0.000433	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—Crohn's disease	0.0003	0.000424	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—JAK2—Crohn's disease	0.000299	0.000422	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000294	0.000415	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—JAK2—Crohn's disease	0.000292	0.000413	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SMAD3—Crohn's disease	0.000283	0.0004	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SMAD3—Crohn's disease	0.000277	0.000392	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—Crohn's disease	0.000272	0.000385	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SMAD3—Crohn's disease	0.000268	0.000378	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—Crohn's disease	0.000267	0.000377	CbGpPWpGaD
Bimatoprost—AKR1C3—lymph node—Crohn's disease	0.000265	0.0594	CbGeAlD
Bimatoprost—PTGFR—Signaling Pathways—IL2RA—Crohn's disease	0.000262	0.000371	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2RA—Crohn's disease	0.000257	0.000363	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TYK2—Crohn's disease	0.000249	0.000352	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2RA—Crohn's disease	0.000248	0.00035	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TYK2—Crohn's disease	0.000247	0.000349	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—JAK2—Crohn's disease	0.000238	0.000336	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JAK2—Crohn's disease	0.000236	0.000333	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—Crohn's disease	0.000225	0.000318	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTGS2—Crohn's disease	0.000224	0.000316	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—Crohn's disease	0.000215	0.000304	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—Crohn's disease	0.000214	0.000303	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—Crohn's disease	0.000205	0.000289	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTGS2—Crohn's disease	0.000187	0.000265	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TYK2—Crohn's disease	0.000185	0.000261	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TYK2—Crohn's disease	0.000181	0.000256	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JAK2—Crohn's disease	0.000176	0.000249	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TYK2—Crohn's disease	0.000175	0.000247	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—Crohn's disease	0.000175	0.000246	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—Crohn's disease	0.000173	0.000244	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JAK2—Crohn's disease	0.000173	0.000244	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAK2—Crohn's disease	0.000167	0.000235	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—Crohn's disease	0.000161	0.000227	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—Crohn's disease	0.000158	0.000222	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—Crohn's disease	0.000153	0.000216	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—Crohn's disease	0.000152	0.000215	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—Crohn's disease	0.00015	0.000212	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—Crohn's disease	0.000129	0.000183	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—Crohn's disease	0.000127	0.000179	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—Crohn's disease	0.000122	0.000173	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—Crohn's disease	0.000122	0.000172	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—Crohn's disease	0.000121	0.000171	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—Crohn's disease	9.04e-05	0.000128	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—Crohn's disease	8.85e-05	0.000125	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—Crohn's disease	8.54e-05	0.000121	CbGpPWpGaD
